cheng-yi huang

About

Dr. Cheng Yi Huang graduated from Taipei Medical College and completed his psychiatric residency at Bali Psychiatric Center. After earning his board certification in psychiatry, he finished a fellowship program in addiction psychiatry at the National Health Research Institutes in Taiwan. In 2013, he was appointed director of the Department of Community Psychiatry at Bali Psychiatric Center, where he has led the department in providing community outreach services and implementing government projects for 12 years.
In academic research, he has over 15 years of experience conducting clinical trials, and his research interests include addictions and schizophrenia. He is also the lead author of the “Taiwanese guidance on the clinical understanding and practice of long-acting injectable antipsychotics in schizophrenia,” published by the Taiwanese Society of Psychiatry.

Employment

• Bali Psychiatric Center Director
  2014 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Influence of Baseline Psychiatric Disorders on Mortality and Suicide and Their Associations with Gender and Age in Patients with Methamphetamine Use Disorder
  International Journal of Mental Health and Addiction 2025 DOI: 10.1007/s11469-023-01025-x
  +Save
• Associations and relative risks of pulmonary hypertension and lung diseases in individuals with methamphetamine use disorder
  Pulmonology 2024 DOI: 10.1016/j.pulmoe.2023.01.003
  +Save
• Co-Occurrence of Gaming Disorder and Drug Dependence in People who Use Stimulants During the Era of COVID-19 Pandemic in Taiwan
  Drug and Alcohol Dependence 2024 DOI: 10.1016/j.drugalcdep.2023.110870
  +Save
• Resilience as a Mediator of Amphetamine Dependence and Psychiatric Symptoms in Deferred Prosecuted Individuals who Use Amphetamine in Taiwan
  Drug and Alcohol Dependence 2024 DOI: 10.1016/j.drugalcdep.2023.110277
  +Save
• Trait Impulsivity as a Mediator Between Early Cigarette Smoking Initiation and Addiction Severity in Patients with Methamphetamine Use Disorder
  International Journal of Mental Health and Addiction 2024 DOI: 10.1007/s11469-022-00872-4
  +Save
• Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia
  The Journal of Clinical Psychiatry 2022 DOI: 10.4088/jcp.21r14153
  +Save
• Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes BSN and PCLO in Schizophrenia and Bipolar Disorder
  Journal of Personalized Medicine 2021 DOI: 10.3390/jpm11111057
  +Save
• Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia
  JAMA Network Open 2021 DOI: 10.1001/jamanetworkopen.2021.8810
  +Save
• The effectiveness of long‐acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia
  Human Psychopharmacology: Clinical and Experimental 2020 DOI: 10.1002/hup.2729
  +Save
• Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study
  Schizophrenia Research 2019 DOI: 10.1016/j.schres.2019.07.049
  +Save
• Cognitive Control in Opioid Dependence and Methadone Maintenance Treatment
  PLoS ONE 2014 DOI: 10.1371/journal.pone.0094589
  +Save
• The reliability of the Chinese version of the Barratt Impulsiveness Scale version 11, in abstinent, opioid-dependent participants in Taiwan
  Journal of the Chinese Medical Association 2013 DOI: 10.1016/j.jcma.2013.01.005
  +Save